Budd–Chiari syndrome has different presentations and disease severity during adolescence

Hepatology International - Tập 12 - Trang 560-566 - 2018
Akash Shukla1, Pratin Bhatt1, Deepak Kumar Gupta1, Tejas Modi1, Jatin Patel1, Amit Gupte1, Megha Meshram1, Shobna Bhatia1
1Department of Gastroenterology, KEM Hospital and Seth GS Medical College, Mumbai, India

Tóm tắt

There are limited data on clinical profile of adolescent patients with Budd–Chiari syndrome (BCS). We studied clinical, radiological, thrombophilia profile and treatment outcomes in adolescent patients with BCS. Forty-three consecutive patients of BCS with onset of symptoms during adolescence (10–19 years) were enrolled in the study. 129 randomly selected adult patients with BCS and 36 children with BCS formed the two control groups. The clinical history, physical examination, laboratory tests, thrombophilic disorders, radiological features and treatment outcomes of adolescents were compared to adults and children. In adolescents, ascites (25/43 vs. 110/129, p = 0.0004) and thrombophilic disorders (16/43 vs. 93/129 p < 0.0001) were less frequent than adults. More adolescents (14/43) presented with hepatomegaly alone without ascites than adults (9/129, p < 0.001) or children (1/36, p = 0.005). Adolescents had lower Clichy scores [3.75 (1.2)] than adults [4.72 (1.3), p < 0.0001) or children [4.43 (1.7), p = 0.041]. JAK-2 V617F mutation was the most common thrombophilic disorder in adolescents (5/43) and more common than children (0/36, p = 0.043). Response to therapy was better in adolescents (74.4%) than children (52.8%, p = 0.038), but similar to adults (63.56%, p = 0.13). During adolescence, patients with BCS present less commonly with ascites and may present with hepatomegaly alone. JAK-2 V617F mutation is the most common thrombophilic disorder during adolescence; though thrombophilic disorders are less common in adolescents than adults. Response to therapy is similar to adults, but better than children.

Tài liệu tham khảo

Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd–Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology. 1998;28(5):1191–1198. https://doi.org/10.1002/hep.510280505 Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd–Chiari syndrome: a study from Western India. Hepatology. 2001;34(4):666–670. https://doi.org/10.1053/jhep.2001.27948 Shukla A, Parikh H, Modi T, et al. Hepatic vein obstruction is the most common type of hepatic venous outflow obstruction regardless of socioeconomic status. Ann Gastroenterol. 2015;28(1):130–4. Singh V, Sinha SK, Nain CK, et al. Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol. 2000;15(5):550–4. Murad SD, Valla D-C, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology. 2004;39(2):500–508. https://doi.org/10.1002/hep.20064 Tang TJ, Batts KP, de Groen PC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol. 2001;35(3):338–43. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003;39(4):496–501. Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167–75. Nagral A, Hasija RP, Marar S, Nabi F. Budd–Chiari Syndrome in Children: experience With Therapeutic Radiological Intervention. J Pediatr Gastroenterol Nutr. 2010;50(1):74–78. https://doi.org/10.1097/MPG.0b013e3181aecb63 Kathuria R, Srivastava A, Yachha SK, Poddar U, Baijal SS. Budd–Chiari syndrome in children. Eur J Gastroenterol Hepatol. 2014;26(9):1030–1038. https://doi.org/10.1097/MEG.0000000000000144 Dubuis JM. Puberty: Physiology. https://www.gfmer.ch/Endo/Lectures_10/Puberty_Physiology.htm. Accessed 11 Dec 2017. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation. 99(1):111–120. https://doi.org/10.1161/01.CIR.99.1.111 Perry RJ, Farquharson C, Ahmed SF. The role of sex steroids in controlling pubertal growth. Clin Endocrinol (Oxf). 2008;68(1):4–15. https://doi.org/10.1111/j.1365-2265.2007.02960.x Shukla A, Bhatia SJ. Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone. Indian J Gastroenterol. 2010;29(1):8–11. https://doi.org/10.1007/s12664-010-0012-5 Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd–Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore). 1994;73(1):21–36. Osgood EE. Polycythemia vera: age relationships and survival. Blood. 1965;26(3):243–256 Cario H, Pahl HL, Schwarz K, et al. Familial polycythemia vera with Budd–Chiari syndrome in childhood. Br J Haematol. 2003;123(2):346–352. https://doi.org/10.1046/j.1365-2141.2003.04591.x Cario H, McMullin MF, Pahl HL. Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol. 2009;88(8):713–719. https://doi.org/10.1007/s00277-009-0758-y Veselovska J, Pospisilova D, Pekova S, et al. Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies. Leuk Res. 2008;32(3):369–377. https://doi.org/10.1016/j.leukres.2007.07.011. Cervera R, Piette J-C, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–27. Saca LF, Szer IS, Henar E, Nanjundiah P, Haddad ZH, Quismorio FP. Budd-Chiari syndrome associated with antiphospholipid antibodies in a child: report of a case and review of the literature. J Rheumatol. 1994;21(3):545–8. Alam S, Khanna R, Mukund A. Clinical and prothrombotic profile of hepatic vein outflow tract obstruction. Indian J Pediatr. 2014;81(5):434–440. Rathod K, Deshmukh H, Shukla A, et al. Endovascular treatment of Budd–Chiari syndrome: single center experience. J Gastroenterol Hepatol. 2017;32(1):237–243. https://doi.org/10.1111/jgh.13456 Wang L, Zu M, Gu Y, et al. Budd–Chiari syndrome in children and adolescents: therapeutic radiological intervention. Chin J Pediatr. 2013;51(8):590–594 Sood V, Khanna R, Rawat D, Alam S. Diagnosis, management, and long-term issues in pediatric Budd–Chiari syndrome. Eur J Gastroenterol Hepatol. 2016;28(9):1102. https://doi.org/10.1097/MEG.0000000000000680